ArticleslgStudy

chemistry

Nivegacetor

Nivegacetor is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Nivegacetor rather than just read about it. In short: Nivegacetor is an investigational gamma-secretase modulator being developed by Roche for the treatment of Alzheimer's disease. The compound is also known by its development code name RG6289 and represents a second-generation gamma-secretase modulator designed to selectively alter amyloid beta peptide production while avoiding the toxicity issues associated with first-generation compounds.

Nivegacetor — main illustration
Nivegacetor — illustration

Key takeaways

  • Nivegacetor belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Nivegacetor to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Nivegacetor from memory before moving on to harder problems.

Reference excerpt

Nivegacetor is an investigational gamma-secretase modulator being developed by Roche for the treatment of Alzheimer's disease. The compound is also known by its development code name RG6289 and represents a second-generation gamma-secretase modulator designed to selectively alter amyloid beta peptide production while avoiding the toxicity issues associated with first-generation compounds.

Mechanism of action Nivegacetor is a gamma-secretase modulator (GSM) that targets the gamma-secretase enzyme complex, which plays a central role in the production of amyloid beta peptides implicated in the pathogenesis of Alzheimer's disease. It specifically modulates the catalytic subunit presenilin-1 (PSEN1), stabilizing the interaction between the complex and the amyloid precursor protein (APP) at the enzyme's active site. This stabilization increases the processivity of APP cleavage—that is, the enzyme's ability to carry out sequential cleavage steps before releasing the APP substrate. Unlike gamma-secretase inhibitors that completely block enzyme function and cause significant side effects, nivegacetor selectively reduces the production of amyloidogenic long amyloid beta peptides, particularly Aβ42 and Aβ40 that form insoluble amyloid fibrils, while simultaneously increasing the formation of shorter, non-amyloidogenic species such as Aβ38 and Aβ37. The compound demonstrates high potency with an IC50 below 10 nM for gamma-secretase modulation of APP cleavage, and importantly shows no effect on the processing of other gamma-secretase substrates, potentially avoiding the toxicity issues that plagued earlier compounds.

Clinical development

Phase I studies Nivegacetor has completed Phase I clinical trials in healthy volunteers, where it demonstrated a favorable safety profile and dose-dependent pharmacodynamic effects. The study showed that treatment with nivegacetor resulted in a dose-dependent shift in amyloid beta monomers in cerebrospinal fluid (CSF), with significant reductions in Aβ42 levels and corresponding increases in shorter amyloid beta species. The Phase I results were presented at the 2023 Clinical Trials on Alzheimer's Disease (CTAD) conference, where researchers reported that nivegacetor appeared safe and effectively shifted amyloid beta production toward smaller, less aggregation-prone peptides.

Phase II studies Based on the positive Phase I results, nivegacetor has been selected for advancement to Phase II clinical trials for Alzheimer's disease treatment. The dose selection for the Phase II study was informed by population pharmacokinetic/pharmacodynamic modeling derived from the Phase I data.

Historical context Nivegacetor represents a significant advancement in gamma-secretase modulator development, addressing the limitations of first-generation compounds that failed due to toxicology problems. Previous attempts at gamma-secretase modulation were hampered by safety concerns and off-target effects, leading to the discontinuation of several promising candidates in the 2000s and early 2010s. The development of nivegacetor as a second-generation GSM reflects improved understanding of gamma-secretase biology and more selective targeting approaches.

References

Illustrations

Nivegacetor illustration

Worked examples

Example 1 — a first encounter with Nivegacetor

Start with the simplest possible case. Write down what Nivegacetor claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Nivegacetor before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Nivegacetor ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Nivegacetor

In research
Nivegacetor appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Nivegacetor in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Nivegacetor is common in secondary-school and first-year university syllabi. It links to neighbouring topics 3,5-Difluorophenyl compounds, Methoxy compounds, Phenoxyethylamines, so understanding it makes those chapters shorter.
In everyday life
Look for Nivegacetor outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Nivegacetor” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Nivegacetor in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Nivegacetor means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Nivegacetor out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Nivegacetor in simple terms?

Nivegacetor is an investigational gamma-secretase modulator being developed by Roche for the treatment of Alzheimer's disease. The compound is also known by its development code name RG6289 and represents a second-generation gamma-secretase modulator designed to selectively alter amyloid beta pepti…

Why does Nivegacetor matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Nivegacetor?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Nivegacetor.

Tags

  • 3,5-Difluorophenyl compounds
  • Methoxy compounds
  • Phenoxyethylamines
  • Piperidines
  • Pyridazines
  • Pyrrolotriazoles

Keep exploring